2024-10-04 2025-10-31 false No description of principal activity Acting Office - Tax and Accounts 1.0 15999503 bus:FullAccounts 2024-10-04 2025-10-31 15999503 bus:Micro-entities 2024-10-04 2025-10-31 15999503 bus:AuditExempt-NoAccountantsReport 2024-10-04 2025-10-31 15999503 bus:SmallCompaniesRegimeForAccounts 2024-10-04 2025-10-31 15999503 bus:PrivateLimitedCompanyLtd 2024-10-04 2025-10-31 15999503 2024-10-04 2025-10-31 15999503 2025-10-31 15999503 bus:RegisteredOffice 2024-10-04 2025-10-31 15999503 core:WithinOneYear 2025-10-31 15999503 core:AfterOneYear 2025-10-31 15999503 2023-10-04 15999503 bus:Director1 2024-10-04 2025-10-31 15999503 bus:Director1 2025-10-31 15999503 bus:CompanySecretary1 2024-10-04 2025-10-31 15999503 bus:LeadAgentIfApplicable 2024-10-04 2025-10-31 15999503 2024-10-03 15999503 core:CostValuation core:Non-currentFinancialInstruments 2025-10-31 15999503 core:CostValuation core:Non-currentFinancialInstruments 2024-10-03 15999503 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-10-31 15999503 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-10-31 15999503 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-10-31 15999503 core:ShareProfitOrLossIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-10-31 15999503 core:ProvisionsForImpairmentInvestments core:Non-currentFinancialInstruments 2025-10-31 15999503 core:ImpairmentReversalProvisionsForImpairmentInvestments core:Non-currentFinancialInstruments 2025-10-31 15999503 core:ForeignExchangeDifferencesIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-10-31 15999503 core:TransfersIntoOrOutInvestmentsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-10-31 15999503 core:TransfersBetweenInvestmentClassesIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-10-31 15999503 core:Non-currentFinancialInstruments 2025-10-31 15999503 core:Non-currentFinancialInstruments 2024-10-03 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 15999503
England and Wales
D GRAHAM MEDICAL LTD
Unaudited Financial Statements
Period of accounts Start date : 04 October 2024 End date : 31 October 2025

D GRAHAM MEDICAL LTD ###### Statement of Financial Position As at 31 October 2025
|  | £ | 2025 £
--- | --- | --- | ---
Current assets |  | 10,001 |
Creditors: amount falling due within one year |  | (3,648) |
Net current assets/(liabilities) |  |  | 6,353
Total assets less current liabilities |  |  | 6,353
Net assets/(liabilities) |  |  | 6,353
Capital and reserves |  |  | 6,353
For the period ended 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476 of the Companies Act 2006. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. The accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime. Signed on behalf of the board of directors:
--------------------------------------------- David George Graham Director |  |
Date approved: 02 July 2026 1

D GRAHAM MEDICAL LTD ###### Notes to the Accounts For the period ended 31 Oct 2025
Statutory Information D Graham Medical Ltd is a private limited company, limited by shares, domiciled in England and Wales, registration number 15999503, registration address 24 Greenham Road, London, N10 1LP, England. The presentation currency is £ sterling.
1. | Accounting Policies Basis of accounting The financial statements are prepared under the historical cost convention and in accordance with the FRS 105 Financial Reporting Standard for Micro Entities (effective January 2016).
2. | Average number of employees Average number of employees during the period was 0.
2